The market for cancer vaccines is poised to dramatically increase to over $7 billion by 2015 – Transworld News

Cancer Vaccines Markets – Cancer vaccines have the potential to become a significant force in future cancer treatments. In 2010, Dendreon’s Provenge became the first cancer vaccine approved by the FDA, generating renewed interest and support for this type of cancer immune therapy. Cancer vaccines …